Senti Biosciences, Inc.
SNTI
$2.10
$0.041.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 4.86% | 8.06% | |||
| Gross Profit | -4.86% | -8.06% | |||
| SG&A Expenses | 54.33% | -4.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.71% | 4.87% | |||
| Operating Income | -21.71% | -4.87% | |||
| Income Before Tax | -23.03% | -4.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.03% | -4.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.03% | -4.40% | |||
| EBIT | -21.71% | -4.87% | |||
| EBITDA | -23.17% | -5.29% | |||
| EPS Basic | -22.34% | 59.92% | |||
| Normalized Basic EPS | -22.32% | 59.92% | |||
| EPS Diluted | -22.34% | 59.92% | |||
| Normalized Diluted EPS | -22.32% | 59.92% | |||
| Average Basic Shares Outstanding | 0.56% | 160.48% | |||
| Average Diluted Shares Outstanding | 0.56% | 160.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||